Peculiarities of multidrug-resistant tuberculosis on the background of idiopathic pulmonary fibrosis (a clinical case report)

Authors

  • O. M. Raznatovska Zaporizhzhia State Medical University, Ukraine,
  • M. O. Shalmina Zaporizhzhia State Medical University, Ukraine,
  • A. V. Fedorets Communal Institution “Zaporizhzhia Regional TB Clinical Dispensary”, Ukraine,
  • O. S. Shalmin Zaporizhzhia State Medical University, Ukraine,
  • M. S. Potapenko Zaporizhzhia State Medical University, Ukraine,

DOI:

https://doi.org/10.14739/2310-1210.2019.4.173363

Keywords:

idiopathic pulmonary fibrosis, multi-drug resistant tuberculosis

Abstract

Objective – familiarization of practitioners with the peculiarities of pulmonary multi-drug resistant tuberculosis (MDRT) in a patient with idiopathic pulmonary fibrosis (IPF) resulted from a long exposure to environmental factors at the workplace.

Materials and methods. The article deals with a clinical case of own observation of pulmonary MDRT development in a patient with IPF. The patient was hospitalized in the Pulmonary Tuberculosis Department No 3 (Department of Resistant Tuberculosis) of the Clinical Site of Phthisiology and Pulmonology Department of Zaporizhizhia State Medical Univercity in the CI “Zaporizhzhia Regional Tuberculosis Clinical Dispensary”.

The results of our own observations. Patient: male, 41 years, no medical history of tuberculosis. His work was associated with a harmful environmental factor within 7 years: dust in the workplace (refueling and repair of powder-type fire extinguishers). After 3 weeks of inpatient treatment, the patient died. The presented clinical case demonstrates the complexity of a life-time IPF diagnosis, which progression provoked the development of an equally serious disease, such as multi-resistant disseminated pulmonary tuberculosis and the prescription of antimycobacterial therapy. The cause of death was a progressive pulmonary fibrosis, and as a result, a progressively worsening pulmonary heart disease.

Conclusions. Practitioners should be especially vigilant and attentive while dealing with a patient having a history of harmful environmental factors exposure that may cause IPF development. It must be borne in mind that IPF may be asymptomatic for a long time resulting in increased risk for developing tuberculosis. This case confirms the literature data that the development of pulmonary MDRT in patients with untreated IPF leads to a rapid fatal outcome in the vast majority of cases (in this case it was 3 weeks).

References

Gavrisyuk, V. K. (2011). Fibroziruyushhie al'veolity [Fibrosing alveolitis]. Klinichna imunolohiia. Alerholohiia. Infektolohiia, 5–12. [in Ukrainian].

Kilessa, V. V. (2009). Idiopaticheskij fibroziruyushhij al'veolit [Idiopathic fibrosing alveolitis]. Tavricheskij mediko-biologicheskij vestnik, 12, 1(45), 173–176. [in Russian].

Travis, W. D., Costabe, U., Hansell, D. M., King, T. E., Lynch, D. A., Nicholson, A. G. et al. (2013). An official American Thoracic Society / European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med, 188(6), 733–748. doi: 10.1164/rccm.201308-1483ST

Averyanov, A. V., & Lesnyak, V. N. (2016). Ot idiopaticheskogo fibroziruyushhego al'veolita k idiopaticheskomu legochnomu fibrozu (Chast' II) [From idiopathic fibrosing alveolitis to idiopatic lungs fibrosis]. Klinicheskaya praktika, 4(28), 58–64. [in Russian].

Avdeev, S. N. (2015). Idiopaticheskij legochnyj fibroz [Idiopathic pulmonary fibrosis]. Pul'monologiya, 25(5), 600–612. doi: 10.18093/0869-189-2015-25-5-600-612 [in Russian].

Il'kovich, M. M., Novikova, L. N., & Speranskaya, A. A. (2009). Idiopaticheskij fibroziruyushhij al'veolit: sovremennye predstavleniya [Idiopathic pulmonary fibrosis: the current view]. Consilium Medicum, 11(11), 24–29. [in Russian].

Ryu, J. H., Moua, T., Daniels, C. E., Hartman, T. E., Yi, E., Utz, J. P., & Limper, A. H. (2014). Idiopathic pulmonary fibrosis: evolving concepts. Mayo. Clin. Proc., 89(8), 1130–1142. doi: 10.1016/j.mayocp.2014.03.016

Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., et al. (2011). An official ATS / ERS / JRS / ALAT statement: idiopathic pulmonary fibrosis; evidence based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med, 183(6), 788–824. doi: 10.1164/rccm.2009-040GL

Novikova, L., Ilkovich, Y.  Speranskaya, A. (2015). Tuberculosis in patients with idiopathic pulmonary fibrosis. European Respiratory Journal, 46(59). doi: 10.1183/13993003.congress-2015.PA2046

(2014). Ukraina. MOZ. Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi) ta tretynnoi (vysokospetsializovanoi) medychnoi dopomohy doroslym. Tuberkuloz [Unified clinical protocols of primary, secondary (specialized) and tertiary (highly specialized) medical care for adults "Tuberculosis"]. [in Ukrainian].

Downloads

How to Cite

1.
Raznatovska OM, Shalmina MO, Fedorets AV, Shalmin OS, Potapenko MS. Peculiarities of multidrug-resistant tuberculosis on the background of idiopathic pulmonary fibrosis (a clinical case report). Zaporozhye Medical Journal [Internet]. 2019Jul.15 [cited 2024Dec.3];(4). Available from: http://zmj.zsmu.edu.ua/article/view/173363

Issue

Section

Case Reports